Product: MECLIZINE HYDROCHLORIDE Classification: Class II Reason for recall: Failed tablet specifications. Product description: Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217. Recalling firm: Amerisource Health Services LLC Product type: Drugs
FDA MedWatch published a clinical safety alert in Pharmacology on 01 Apr 2026.
The item focuses on MECLIZINE HYDROCHLORIDE: Class II recall update.
Review the original article for the full source wording and details.